Drug interactions - adverse effects Flashcards

1
Q

Adverse drug effects statistics

A

2.9 - 3.7% of hospitalizations involve adverse events
4th leading cause of death
Drug poisoning accounting for 1 in 7 deaths among
people in their 20s and 30s in 2014 in UK
Majority of deaths in males
Adverse events occur in 10-20% of hospitalized patients.
7% of those in ambulatory setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Type A reactions

A

pharmacological or toxic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type B reactions

A

iodiosyncrasy and drug allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Typical pharmacopeia in dental practice

A

Sedative
Local anesthetic
Analgesic
Antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Therapeutic index

A

The therapeutic index varies widely among substances
GRAPH
Know the TI for drugs we use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Therapeutic index remifentanyl

A

Opioid analgesic

33000:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Therapeutic index diazepam

A

Benzodiazepine sedative, muscle relaxant

100:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Therapeutic index morphine

A

Opioid analgesic

70:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs with low therapeutic index

A

Anticoagulant i.e. warfarin
Aminoglycoside antibiotics i.e. gentamicin
Anticonvulsants i.e. phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Circumstances

A

Accidental or deliberate overdose

Normal therapy -side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Site of action

A

Localized
-aspirin (mouth ulcers, GI irritation)
Systemic
-majority of reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Time course

A

Acute toxicity- single intake/rapid onset
-narcotics (i.e. respiratory depression)
Sub-acute toxicity-repeated exposure (hours/days)
-tetracycline (i.e. renal impairment)
Chronic toxicity- repeated exposure (months/years)
-chemical carcinogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanisms - Type A

A

For augmented

  • exaggerated therapeutic responses
  • secondary unwanted actions
  • more predictable or anticipated effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanisms - type B

A

For bizarre
Pharmacologically unexpected, unpredictable, or idiosyncratic
adverse reactions
-immunologic (Allergic or anaphylactic)
-idiosyncratic (Qualitatively abnormal adverse reactions
that occur in a given individual and whose mechanism
is not yet understood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Type A reactions - major concerns

A
Respiratory depression (i.e. narcotic agents)
Cardiac toxicity (i.e. overdose of intravascular
injection of local anesthetic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type A reactions - minor concerns

A

Diarrhea (Broad spectrum antibiotics)
Dry mouth (Anticholinergics i.e. antidepressant)
Drowsiness (CNS drugs i.e. benzodiazepines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Higher dose –>

A

Higher possibility of side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Type A reactions - risk situation

A

Childhood

  • Elderly
  • Pregnancy
  • Lactation
  • Renal failure
  • Haemodialysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Type A reactions - pharmacokinetics

A
Absorption
Distribution
Metabolism
Excretion
-each step is a target for adverse effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type A reactions - absorption/ distribution (tetracycline)

A

Absorption reduced by chelation of drugs/food/vitamins/
divalent cations (i.e. milk)
Distribution sequestration of tetracycline in bone (tissue
binding) leading to depression of bone growth in children and
irreversible staining of tooth enamel
No to be prescribed in pregnant women and children under 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type A reactions - absorption GRAPH

A

Antiacids and iron preparation
decrease absorption by
chelation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Type A reactions - metabolism

A

Some important preventable drug interactions are due to their
effects on drug metabolizing enzymes, resulting in inhibition of
enzyme or induction of enzyme
Diseases may alter drug metabolism (i.e. renal and hepatic
dysfunction)
Abnormal drug metabolism may be due to inherited factors of either
Phase I oxidation or Phase II conjugation
Polypharmacy risk of drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Type A reactions - excretion

A

Renal excretion of drugs mainly controlled by: glomerular
filtration, tubular secretion and tubular reabsorption.
Factors affecting renal excretion of drugs include: kidney
function, protein binding, urine pH and urine flow.
Impaired renal function may lead to clinically significant
accumulation of drugs eliminated by the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Type B reaction

A
No dose relationship
Unexpected
Mechanism uncertain
Causality uncertain
Not reproducible
Characteristic, serious
Suggestive time relationship
Low background frequency
Immunoallergic reactions
Pseudoallergy
Metabolic intolerance
Idiosyncrasy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Type B reaction examples

A

Anaphylaxis, Stevens-Johnson syndrome, Blood

dyscrasias, Hepatitis

26
Q

Type A vs Type B reaction

A
Pharmacalogically predictable - A
Dose dependent - A
Incidence and morbidity
-A high
-B low
Mortality
-A low
-B high
Treatment
-A decrease dose
-B stop
Many are due to conversion of drugs in active metabolites
27
Q

Valproic acid in pregnant women

A
Antiepileptic used to control certain types of seizures
Fetal valproate  syndrome: facial features
-broad forehead
-epicanthal folds
-flat nasal brdige
-short anteverted nose
-long philtrum
-thin upper lip
28
Q

Drug allergy characteristics

A

Delay after initial exposure (up to a week)
Precipitated with small doses of drug
Does not resemble normal pharmacology
Classical symptoms of allergic response

29
Q

Drug allergy dependent on

A

Drug related factors

Host related factors

30
Q

Drug related factors

A

Nature of the drug
Degree of exposure (dose, duration, frequency and repeated
administration)
Route of administration (i.e. allergic reactions to penicillins
occur more frequently parenteral rather than oral
administration)
Cross sensitisation (reactivity either to drugs with a close
structural chemical relationship or to immunochemically
similar metabolites

31
Q

Host related factors

A
Age (between 20 and 49 at higher risk of allergic reactions)
Sex (slightly more common in women)
Genetic factors
Diseases
Previous exposure
32
Q

Anaphylaxis plus incidence

A

Acute response
Potentially fatal
Incidence: drug related 3 per 100000 (1800 in UK). Deaths
1-2 per 100000

33
Q

Anaphylaxis mechanism

A

release of inflammatory mediators from mast

cells to tissue oedema/damage

34
Q

Anaphylaxis: signs and symptoms

A
Welling of conjunctiva
Runny nose
Swelling of lips, tongue and/ or throat
Heart rate fast/ slow, low BP
Hives, itchiness, flushing
Pelvic pain
Loss of bladder control
Crampy abdo pain, diarrhoea, vomiting
Shortness of breath, wheezes or stridor, hoarseness, pan with swallowing, cough
Lightheadedness, confusion, headache, anxiety
35
Q

Anaphylaxis in dentistry - deaths from

A

Penicinillin (75% of anaphylactic deaths)
Aspirin
Local anaesthetics: procaine, lidocaine (rare)

36
Q

Anaphylaxis in dentistry - treatment

A

Adrenaline (im)
Antihistamine (chlorphenamine)
Steroids (hydrocortisone)
Bronchodilator (β agonist/aminophylline)

37
Q

Stephen/ Johnson syndrome can be caused by

A
Anti-gout medications, (allopurinol)
Pain relievers -acetaminophen (i.e.Tylenol)
-ibuprofen (Advil, Motrin IB)
-naproxen sodium (Aleve)
Antibiotic - penicillin
Medications to treat seizures or mental illness (i.e
anticonvulsants and antipsychotics)
Radiation therapy
38
Q

Drug toxicity in dentistry

A

A limited range but regularly used drug
Probably injected more drugs than average GP
Most drugs on dental list are safe
Unlikely to see much toxicology (recognition)
Important to recognise, treat/report adverse drug reactions

39
Q

Drug-drug interactions

A

No effect
Beneficial effect
Toxic

40
Q

Drug-drug interactions mechanisms

A
Pharmaceutical
Pharmacodynamic
Pharmacokinetic Absorption
-distribution
-metabolism
-excretion
41
Q

LA and vasoconstrictor

A

LIDOCAINE + ADRENALINE
Adrenaline enhances therapeutic effect of lidocaine by slowing
absorption from site of action into systemic circulation
–>prolonged more intense anaesthesia
–>reduced bleeding
–>reduced systemic toxicity

42
Q

Pharmacodynamics - warfarin

A

> risk of anticoagulation (negatively interacts with
vitamin K)
Warfarin antagonises the recycling of vitamin K by depleting
active vitamin K in the liver

43
Q

Pharmacokinetic: metabolism

A

Not for water soluble drugs (i.e. penicillins)
Drugs metabolized in the liver - substrates of the cytochrome
P450 enzymes (i.e. sedative and analgesics)
Enzyme inhibitors - increase blood levels (i.e. antibiotics)
Enzyme inducers - reduce blood levels
Glass of grapefruit juice doubles
plasma concentration of midazolam
RISK oversedation, airway
obstruction

44
Q

Cytochrome CYP3A**

A
Inducers
-carbamazepine
-phenytoin
-rifampicin
-glucocorticoids
-st. John’s Wort
Substrates
-midazolam or other
benzodiazepines
-cyclosporin
-methadone
-statins
-HIV protease
Inhibitors 
-erythromycin
-ketaconazole
-itraconazole
-grapefruit juice
-omeprazole
45
Q

Erythromycin

A
Increases effect of : Warfarin
Carbamazepine
Theophylline
Cyclosporin
-by inhibition of CYP 450
46
Q

Midazolam (GRAPH)

A
Increased plasma concentration by : Erythromycin
Ketoconazole ( or
other antifungal)
Omeprazole
Grapefruit juice 
-CYP3A inhibition
47
Q

CYP3A induction (GRAPH)

A

Induction of enzyme activity particularly cytochrome P450

Requires synthesis of new enzymes

48
Q

St John’s Wort found in

A

Hypericum perforatum
Extract of leaf and golden flowers
Hyepericin (anthracene)
Hyperforin (phenol)

49
Q

St John’s Wort

A

Enhances metabolism of drugs, reducing their plasma levels,
by inducing CYP3A
Oral contraceptive RISK unwanted pregnancies
Immunosuppressant RISK organ rejection
Can also interact with midazolam, methadone and others

50
Q

Acetaldehyde dehydrogenase

A

Metronidazole + Alcohol
–>nausea, vomiting, flushing, tachycardia, shortness of breath,
headache
> levels of acetaldehyde through inhibition of
acetaldehyde dehydrogenase?
(Non CYP interaction)
–> No alcohol consumption

51
Q

Antibiotic/ Antifungal agents

A

In dental practice duration more prolonged than other treatments
increasing risks of interactions – liver enzyme inhibitors
CYP1A2, CYP2C9

52
Q

CYP1A2

A

Macrolides (erythomycin)
Substrates
-antidepressant
-major tranquilisers

53
Q

CYP2C9**

A
Azole antifungal
(metronidazole/
ketoconazole)
Substrates
-warfarin
-phenytoin
-lidocaine (no interaction)
-midazolam (airway obstruction in children)
Many inhibitors
Major area of interactions
54
Q

Lidocaine and the liver

A

CYP3A4 substrate
-clearance limited by hepatic blood flow rather than
metabolism (45 min half life)
-hepatic blood flow reduced by propanolol
-hepatic enzyme metabolism inhibited by cimetidine

55
Q

LA

A

Safe - few adverse effect if used within dosage guidelines
Inhibit neuronal activity in brain and heart
Excessive dosage - Local anaesthetics addictive effect, care
with combined use
Initially CNS stimulation by depressing inhibitory pathways:
tremor/convulsion
Followed by CNS depression: lethargy, respiratory
depression, unconsciousness

56
Q

Mortality due to LAs

A

Healthy 5 years old booked for multiple extractions
Injected 5 cartridges (270mg) of 3% mepivacaine
Convulsion occurred 10 min later followed by full
cardiopulmonary arrest
Dies four days later from anoxic brain injury secondary to
complete pulpal anaesthesia
-based on px weight, max safe dose = 72mg
-nearly 4x higher
-low safety margin for LA in children
-maximum safe doses more rapidly reached with 3%

57
Q

Lidocaine and opioid sedation

A

Local anaesthetics – membrane depressant CNS, CVS
Maximum safe doses determined by body weight
Potential problem in pediatric dentistry
Children- body weight is NOT proportional to difference in
orofacial anatomy
Need for apparent higher doses in children
Multiple mechanisms – convulsions, respiratory,
depression and cardiac arrest

58
Q

Adrenaline (alpha/ beta agonists)

A

α1 vasoconstriction – skin and mucous membrane
β2 vasodilation – skeletal muscle properties add to safety
Compromised patients – reduce the dose, test the dose

59
Q

Adrenaline cases

A

Yagiela (1991) – 58 yrs man died of angina, pervious MI
received 0.18 mg of adrenaline
Campbell (1996) 70 yrs patient no adverse effects
arrhythmia + CVS medication, received 0/04 mg adrenaline

60
Q

Adrenaline - potentiation

A
Non selective β blockers
Tetracycline antidepressants – inhibit
uptake
Cocaine – inhibit uptake
Ritalin – ADHA (release endogenous
norepinephrine)
Parkinson’s disease (COMT
inhibitors reduce breakdown)
Felypressin – alternative
vasoconstriction
61
Q

Benzodiazepines

A
Anxiolytic without sedation or ataxia
Temazepam/diazepam
Large margin safety – wide therapeutic index
Liver CYP3A4
Inhibition (increased plasma levels)
Calcium channel blockers /macrolide / azole antifungal/
protease inhibitors
Induction (decreased plasma levels)
Anti-TB, anti epileptic